subsequent lines of therapy in alk-rearranged mnsclc
Published 3 years ago • 90 plays • Length 7:27Download video MP4
Download video MP3
Similar videos
-
8:02
updates informing the management of alk-rearranged mnsclc
-
1:34
second-line treatments in alk-rearranged nsclc
-
8:56
sequencing therapies in alk-rearranged nsclc
-
3:13
available therapies for alk-rearranged nsclc
-
7:03
sequencing therapies for alk-rearranged nsclc
-
9:33
second-line brigatinib for alk/ros1-rearranged nsclc
-
4:05
the evolution of alk/ros1-targeted therapy in nsclc
-
3:55
treatment considerations in alk/ros-1–rearranged nsclc
-
6:27
alk inhibitor sequencing in nsclc
-
4:28
changing the treatment paradigm for alk-rearranged nsclc
-
4:43
upfront therapy for alk/ros1-rearranged nsclc
-
9:33
second-line brigatinib for alk/ros1-rearranged nsclc
-
8:24
second-line treatment for alk-positive nsclc
-
5:30
sequencing therapy in alk/ros1-rearranged nsclc
-
8:24
second-line treatment for alk-positive nsclc
-
8:09
second-line therapy in alk nsclc
-
7:02
crizotinib for alk-rearranged nsclc
-
1:08:32
management of alk rearranged nsclc in first line.
-
2:48
targeted therapy resistance mechanisms in alk nsclc